On Oct. 19, 2026, the Associated Press has reported that when the Trump administration began upending U.S. scientific…
On Oct. 15, 2026, the South China Morning Post reported that leading life scientist Wu Jun, who recently…
On Oct. 15, 2026, SimBioSys®, an AI-driven precision medicine company revolutionizing how cancer is understood and treated, today…
On Oct. 14, 2026, this fall, the Massachusetts Institute of Technology, where 95% of students are STEM majors,…
On Oct. 6, 2026, the state of Utah expanded its controversial healthcare AI program with three new pilots…
On Oct. 1, 2026, researchers at the University of California, San Francisco (UCSF) have found that as women…
On Sept. 15, 2026, Oregon billionaires Phil and Penny Knight committed $1.1 billion to the Providence St. Vincent…
On Sept. 15, 2026, the U.S. Food and Drug Administration announced the final design of the Expedited Investigational…
On Sept. 4, 2026, the U.S. Food and Drug Administration (FDA) announced they have expanded treatment options for…
On Aug. 25, 2026, the U.S. Centers for Disease Control and Prevention (CDC) reported that In 2024, the…
On Aug. 10, 2026, the Institute for Health Metrics and Evaluation (IHME), an independent research organization at the…
On Jul. 30, 2026, a study led by Cedars-Sinai Health Sciences University investigators found that women who test…
On Jul. 14, 2026, the Food and Drug Administration approved gedatolisib (Revtorpyk, Celcuity) in combination with fulvestrant, with…
On July 9, 2026, researchers at the University of British Columbia announced they have identified a new form of hereditary…
On Jul. 7, 2026, the Association of American Universities (AAU) released new data showing that major research universities…
On Jul. 1, 2026, tech giant Anthropic announced it has extended its foray into the life sciences space…
On Jun. 29, 2026, AstraZeneca and Daiichi Sankyo’s announced that Enhertu (trastuzumab deruxtecan) had been approved in the…
On Jun. 24, 2026, Gilead Sciences announced that the U.S. Food and Drug Administration (FDA) has approved Trodelvy®…
On May 22, 2026, Gilead Sciences announced announced that the U.S. Food and Drug Administration (FDA) has granted…
On May 22, 2026, Gilead Sciences announced that the Committee for Medicinal Products for Human Use (CHMP) of…
On Apr. 23, 2026, a multidisciplinary research team from the Chinese University of Hong Kong’s Faculty of Medicine…
On Apr. 8, 2026, the Trump administration will not be asking the Supreme Court to take up its…
On Apr. 7, 2026, LifeScienceHistory.com, formerly WashingtonLifeScience.com, announces release of a report highlighting the challenges of Washington State’s…
On Mar. 20, 2026, Novartis announced an agreement with Synnovation Therapeutics, to acquire SNV4818, a pan-mutant‑selective PI3Kα inhibitor,…
On Mar. 19, 2026, a nationwide STAT survey of federally funded researchers reveals that, a year after Donald…
On Mar. 18, 2026, the National Institutes of Health (NIH) announced more than $150 million to develop and…
On Mar. 10, 2026, researchers from the University of California San Diego have found that a novel blood-based…
On Feb. 24, 2026, Womb Transplant UK announced in an historic breakthrough, that a bouncing baby boy has…
On Feb. 12 2026, the Trump administration revoked a scientific finding that long has been the central basis…
On Feb. 3, 2026, the World Health Organization (WHO) and its International Agency for Research on Cancer (IARC)…